Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.

In this paper we report on the performances of full-scale conventional activated sludge (CAS) treatment and two pilot-scale membrane bioreactors (MBRs) in eliminating various pharmaceutically active compounds (PhACs) belonging to different therapeutic groups and with diverse physico-chemical properties. Both aqueous and solid phases were analysed for the presence of 31 pharmaceuticals included in the analytical method. The most ubiquitous contaminants in the sewage water were analgesics and anti-inflammatory drugs ibuprofen (14.6-31.3 microg/L) and acetaminophen (7.1-11.4 microg/L), antibiotic ofloxacin (0.89-31.7 microg/L), lipid regulators gemfibrozil (2.0-5.9 microg/L) and bezafibrate (1.9-29.8 microg/L), beta-blocker atenolol (0.84-2.8 microg/L), hypoglycaemic agent glibenclamide (0.12-15.9 microg/L) and a diuretic hydrochlorothiazide (2.3-4.8 microg/L). Also, several pharmaceuticals such as ibuprofen, ketoprofen, diclofenac, ofloxacin and azithromycin were detected in sewage sludge at concentrations up to 741.1, 336.3, 380.7, 454.7 and 299.6 ng/g dry weight. Two pilot-scale MBRs exhibited enhanced elimination of several pharmaceutical residues poorly removed by the CAS treatment (e.g., mefenamic acid, indomethacin, diclofenac, propyphenazone, pravastatin, gemfibrozil), whereas in some cases more stable operation of one of the MBR reactors at prolonged SRT proved to be detrimental for the elimination of some compounds (e.g., beta-blockers, ranitidine, famotidine, erythromycin). Moreover, the anti-epileptic drug carbamazepine and diuretic hydrochlorothiazide by-passed all three treatments investigated. Furthermore, sorption to sewage sludge in the MBRs as well as in the entire treatment line of a full-scale WWTP is discussed for the encountered analytes. Among the pharmaceuticals encountered in sewage sludge, sorption to sludge could be a relevant removal pathway only for several compounds (i.e., mefenamic acid, propranolol, and loratidine). Especially in the case of loratidine the experimentally determined sorption coefficients (Kds) were in the range 2214-3321 L/kg (mean). The results obtained for the solid phase indicated that MBR wastewater treatment yielding higher biodegradation rate could reduce the load of pollutants in the sludge. Also, the overall output load in the aqueous and solid phase of the investigated WWTP was calculated, indicating that none of the residual pharmaceuticals initially detected in the sewage sludge were degraded during the anaerobic digestion. Out of the 26 pharmaceutical residues passing through the WWTP, 20 were ultimately detected in the treated sludge that is further applied on farmland.

[1]  Mats Tysklind,et al.  Behavior of fluoroquinolones and trimethoprim during mechanical, chemical, and active sludge treatment of sewage water and digestion of sludge. , 2006, Environmental science & technology.

[2]  D. Barceló,et al.  Determination of pharmaceuticals in sewage sludge by pressurized liquid extraction (PLE) coupled to liquid chromatography-tandem mass spectrometry (LC-MS/MS) , 2009, Analytical and bioanalytical chemistry.

[3]  Diana S Aga,et al.  Evaluating the biodegradability of sulfamethazine, sulfamethoxazole, sulfathiazole, and trimethoprim at different stages of sewage treatment , 2005, Environmental toxicology and chemistry.

[4]  D. Calamari,et al.  Removal of pharmaceuticals in sewage treatment plants in Italy. , 2006, Environmental science & technology.

[5]  Adriano Joss,et al.  Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. , 2005, Environmental science & technology.

[6]  Hing-Biu Lee,et al.  Determination of β-blockers and β2-agonists in sewage by solid-phase extraction and liquid chromatography–tandem mass spectrometry , 2007 .

[7]  N. Paxéus.  Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.

[8]  Thorsten Reemtsma,et al.  Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. , 2005, Water research.

[9]  Oliver A.H. Jones,et al.  Partitioning Behavior of Five Pharmaceutical Compounds to Activated Sludge and River Sediment , 2006, Archives of environmental contamination and toxicology.

[10]  Adriano Joss,et al.  A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge. , 2004, Water research.

[11]  J Tolls,et al.  Sorption of veterinary pharmaceuticals in soils: a review. , 2001, Environmental science & technology.

[12]  H Kroiss,et al.  Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. , 2005, Water research.

[13]  Adriano Joss,et al.  Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. , 2007, The Science of the total environment.

[14]  Marta Carballa,et al.  Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. , 2004, Water research.

[15]  Mira Petrovic,et al.  Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor , 2006, Analytical and bioanalytical chemistry.

[16]  W. Giger,et al.  Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil. , 2003, Environmental science & technology.

[17]  D. Barceló,et al.  Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. , 2006, Talanta.

[18]  Adriano Joss,et al.  Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. , 2006, Water research.

[19]  T. Tuhkanen,et al.  Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. , 2005, Water research.

[20]  Diana S Aga,et al.  Investigating the molecular interactions of oxytetracycline in clay and organic matter: insights on factors affecting its mobility in soil. , 2004, Environmental science & technology.

[21]  Xiu-Sheng Miao,et al.  Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. , 2005, Environmental science & technology.

[22]  Damià Barceló,et al.  First evidence for occurrence of hydroxylated human metabolites of diclofenac and aceclofenac in wastewater using QqLIT-MS and QqTOF-MS. , 2008, Analytical chemistry.

[23]  Yoshimasa Watanabe,et al.  Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors. , 2007, Environmental science & technology.

[24]  Taro Urase,et al.  Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process. , 2005, Water research.

[25]  Max Maurer,et al.  Elimination of β-blockers in sewage treatment plants , 2007 .

[26]  Adriano Joss,et al.  Removal of pharmaceuticals and fragrances in biological wastewater treatment. , 2005, Water research.

[27]  M. Carballa,et al.  Determination of the solid-water distribution coefficient (Kd) for pharmaceuticals, estrogens and musk fragrances in digested sludge. , 2008, Water research.

[28]  M. Birkved,et al.  Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. , 2000, Chemosphere.

[29]  E. Thurman,et al.  Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002 .

[30]  Dirk Löffler,et al.  Determination of pharmaceuticals, iodinated contrast media and musk fragrances in sludge by LC/tandem MS and GC/MS. , 2005, Journal of chromatography. A.

[31]  Oliver A.H. Jones,et al.  Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. , 2002, Water research.

[32]  R Gnirss,et al.  Outcomes of a 2-year investigation on enhanced biological nutrients removal and trace organics elimination in membrane bioreactor (MBR). , 2005, Water science and technology : a journal of the International Association on Water Pollution Research.

[33]  T. Ternes.  Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus , 1998 .

[34]  Charles S Wong,et al.  Stereoisomer quantification of the β-blocker drugs atenolol, metoprolol, and propranolol in wastewaters by chiral high-performance liquid chromatography–tandem mass spectrometry , 2006 .